Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy
K.C. Johnson*, A.K. Aragaki, R. Jackson, A. Reiner, P.M. Sandset, J. Rosing, A.E.A. Dahm, F. Rosendaal, J.E. Manson, L.W. Martin, S.M. Liu, L.H. Kuller, M. Cushman, J.E. Rossouw
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy'. Together they form a unique fingerprint.